Dr David Almeida shares two cases of neovascular AMD from his practice, one treatment-naïve and one previously treated, and presents his findings after switching them to faricimab.
David Almeida, MD, MBA, PhD
Advertisement
Articles by David Almeida, MD, MBA, PhD
David Almeida, MD, MBA, PhD, reviews the objectives and design of the TRUCKEE study, and discusses the visual and anatomic outcomes after one and three injections of faricimab in neovascular AMD.
Advertisement
Latest Updated Articles
Two Faricimab Patient Cases from the Real-world in Neovascular AMDPublished: April 18th 2023 | Updated:
- Study Design and Preliminary Results From the TRUCKEE Study Evaluating Faricimab in Real-World Neovascular AMD Patients
Published: April 18th 2023 | Updated:
Advertisement
Advertisement
Trending on Modern Retina
1
Sydnexis receives CRL from the FDA for its SYD-101 pediatric myopia drug
2
Retinoblastoma: Decreasing mortality, morbidity, and enucleation
3
AAO 2025: Anatomic and functional outcomes of pegcetacoplan in GALE extension study
4
